Effects of growth hormone secretagogues on prolactin release in anesthetized dwarf (dw/dw) rats

Endocrinology

Volumn 139, Issue 8, 1998, Pages 3590-3596

  Carmignac, Danielle F ^a   Bennett, Pamela A ^a   Robinson, Iain C A F ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; ESTROGEN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PROLACTIN; PROTIRELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DWARFISM; ESTROGEN THERAPY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN EXPRESSION; RAT; THALAMUS VENTRAL NUCLEUS;

EID: 0031761838     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.8.6148     Document Type: Article

References (57)

1. Bowers CY, Momany F, Reynolds GA, Hong A 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114:1537-1545
2. Smith RG, Cheng K, Schoen WR, Pong SS, Hickey G, Jacks T, Butler B, Chan WWS, Chaung LYP, Judith F, Taylor J, Wyvratt MJ, Fisher MH 1993 A nonpeptidyl growth hormone secretagogue. Science 260:1640-1643
3. Patchett AA, Nargund RP, Tata JR, Chen MH, Barakat KJ, Johnston DB, Cheng K, Chan WW, Butler B, Hickey G, et al 1995 Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci USA 92:7001-7005
4. Smith RG, Van der Ploeg LHT, Howard AD, Feighner SD, Cheng K, Hickey GJ, Wyvratt MJ, Fisher MH, Nargund RP, Patchett AA 1997 Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18:621-645
5. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong S-S, Chaung L-YP, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund RP, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LHT 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 27:3974-3977
6. McKee KK, Palyha OC, Feighner SD, Hreniuk DL, Tan CP, Phillips MS, Smith RG, Van der Ploeg L, Howard AD 1997 Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol Endocrinol 11:415-423
7. Smith RG, Pong SS, Hickey G, Jacks T, Cheng K, Leonard R, Cohen CJ, Arena JP, Chang CH, Drisko J, Wyvratt M, Fisher M, Nargund R, Patchett A 1996 Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog Horm Res 51:261-285
8. Guan X-M, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJS, Smith RG, Van der Ploeg LHT, Howard AD 1997 Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 48:23-29
9. Bennett PA, Thomas GB, Howard AD, Feighner SD, Van der Ploeg LHT, Smith RG, Robinson ICAF 1997 Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 138:4552-4557
10. Dickson SL, Leng G, Robinson ICAF 1993 Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neuroscience 53:303-306
11. Ilson BE, Jorkasky DK, Curnow RT, Stote RM 1989 Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab 69:212-214
12. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 70:975-982
13. Gertz BJ, Barrett JS, Eisenhandler R, Krupa DA, Wittreich JM, Seibold JR, Schneider SH 1993 Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab 77:1393-1397
14. Hickey G, Jacks T, Judith F, Taylor J, Schoen WR, Krupa D, Cunningham P, Clark J, Smith RG 1994 Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles. Endocrinology 134:695-701
15. Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R 1996 Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Clin Endocrinol 45:341-351
16. Thomas GB, Fairhall KM, Robinson ICAF 1997 Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 138:1585-1591
17. Copinschi G, Van Onderbergen A, L'Hermite BM, Mendel CM, Caufriez A, Leproult R, Bolognese JA, De Smet, M, Thorner MO, Van Cauter E 1996 Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. J Clin Endocrinol Metab 81:2776-2782
18. Massoud A, Hindmarsh P, CG B 1996 Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study. J Clin Endocrinol Metab 81:4338-4341
19. Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F 1997 Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. J Clin Endocrinol Metab 82:2439-2444
20. Kirk SE, Gertz BJ, Schneider SH, Hartman ML, Pezzoli SS, Wittreich JM, Krupa DA, Seibold JR, Thorner MO 1997 Effect of obesity and feeding on the growth hormone (GH) response to the GH secretagogue L-692,429 in young men. J Clin Endocrinol Metab 82:1154-1159
21. Elias KA, Ingle GS, Burnier JP, Hammonds RG, McDowell RS, Rawson TE, Somers TC, Stanley MS, Cronin MJ 1995 In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology 136:5694-5699
22. Hickey GJ, Drisko J, Faidley T, Chang C, Anderson LL, Nicolich S, McGuire L, Rickes E, Krupa D, Feeney W, Friscino B, Cunningham P, Frazier E, Chen H, Laroque P, Smith RG 1996 Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J Endocrinol 148:371-380
23. Aloi JA, Gertz BJ, Hartman ML, Huhn WC, Pezzoli SS, Wittreich JM, Krupa DA, Thorner MO 1994 Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects. J Clin Endocrinol Metab 79:943-949
24. Ciccarelli E, Grottoli S, Razzore P, Gianotti L, Arvat E, Deghenghi R, Camanni G, Ghigo E 1996 Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients. Clin Endocrinol (Oxf) 44:67-71
25. Jacks T, Smith R, Judith F, Schleim K, Frazier E, Chen H, Krupa D, Hora DJ, Nargund R, Patchett A, Hickey G 1996 MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles. Endocrinology 137:5284-5289
26. Charlton HM, Clark RG, Robinson ICAF, Porter-Goff AE, Cox BS, Bugnon C, Bloch BS 1988 Growth hormone-deficient dwarfism in the rat: a new mutation. J Endocrinol 119:51-58
27. Dickson SL, Doutrelant VO, Leng G 1995 GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6. J Endocrinol 146:519-526
28. Bartlett JMS, Charlton HM, Robinson ICAF, Nieschlag E 1990 Pubertal development and testicular function in the male growth hormone-deficient rat. J Endocrinol 126:193-201
29. Carmignac DF, Gabrielsson BG, Robinson ICAF 1993 Growth hormone binding protein in the rat: effects of gonadal steroids. Endocrinology 133:2445-2452
30. Carmignac DF, Robinson ICAF 1990 Growth hormone (GH) secretion in the dwarf rat: release, clearance and responsiveness to GH-releasing factor and somatostatin. J Endocrinol 127:69-75
31. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF 1995 Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80:942-947
32. 2 (GHRP-6) in the rat. Endocrinology 117:1441-1447
33. Bercu BB, Weideman CA, Walker RF 1991 Sex differences in growth hormone (GH) secretion by rats administered GH-releasing hexapeptide. Endocrinology 129:2592-2598
34. Mallo F, Alvarez CV, Benitez L, Burguera B, Coya R, Casanueva FF, Dieguez C 1993 Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-induced GH secretion in the rat. Neuroendocrinology 57:247-256
35. Ghigo E, Arvat E, Muccioli G, Camanni F 1997 Growth hormone-releasing peptides. Eur J Endocrinol 136:445-460
36. Penalva A, Pombo M, Carballo A, Barreiro J, Casanueva FF, Dieguez C 1993 Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6. Clin Endocrinol (Oxf) 38:87-91
37. Arvat E, Gianotti L, Broglio F, Maccagno B, Bertagna A, Deghenghi R, Camanni F, Ghigo E 1997 Oestrogen replacement does not restore the reduced GH-releasing activity of hexarelin, a synthetic hexapeptide, in post- meno-pausal women. Eur J Endocrinol 136:483-487
38. Bellone J, Ghizzoni L, Aimaretti G, Volta C, Boghen MF, Bernasconi S, Ghigo E 1995 Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. Eur J Endocrinol 133:425-429
39. Clark RG, Carlsson LMS, Trojnar J, Robinson ICAF 1989 The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. J Neuroendocrinol 1:249-255
40. Bowers CY, Veeraragavan K, Sethumadhavan K 1994 Atypical growth hormone peptides. In: Bercu BB, Walker R (eds) Growth Hormone. Springer-Verlag, New York, vol 2:203-222
41. Bercu BB, Yang SW, Masuda R, Walker RF 1992 Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone. Endocrinology 130:2579-2586
42. Arvat E, di Vito L, Maccagno B, Broglio F, Boghen M, Deghenghi R, Camanni F, Ghigo E 1997 Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides 18:885-891
43. Malozowski S, Hao EH, Ren SG, Marin G, Liu L, Southers JL, Merriam GR 1991 Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non-GHRH-mediated responses. J Clin Endocrinol Metab 73:314-317
44. Jaffe CA, Ho PJ, R. DF, Bowers CY, Barkan AL 1993 Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J Clin Endocrinol Metab 77:1641-1647
45. Goth MI, Lyons CJ, Ellwood MR, Barrett JR, Thorner MO 1996 Chronic estrogen treatment in male rats reveals mammosomatotropes and allows inhibition of prolactin secretion by somatostatin. Endocrinology 137:274-280
46. Toney TW, Pawsat DE, Fleckenstein AE, Lookingland KJ, Moore KE 1992 Evidence that prolactin mediates the stimulatory effects of estrogen on tuberoinfundibular dopamine neurons in female rats. Neuroendocrinology 55:282-289
47. Dickson SL, Luckman SM 1997 Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 138:771-777
48. Dickson SL, Doutrelant VO, Dyball RE, Leng G 1996 Retrogradely labelled neurosecretory neurones of the rat hypothalamic arcuate nucleus express Fos protein following systemic injection of GH-releasing peptide-6. J Endocrinol 151:323-331
49. Phelps CJ, Thomas GB, Robinson ICAF, Differential changes in tuberinfuncibular dopamine neurones in spontaneous dwarf (dw) and transgenic growth-retarded (Tgr) rats. 79th Annual Meeting of The Endocrine Society, Minneapolis MN, 1997 (Abstract P1-77)
50. Kimura N, Arai K, Sahara Y, Suzuki H, Kimura N 1994 Estradiol transcriptionally and posttranscriptionally up-regulates thyrotropin-releasing hormone receptor messenger ribonucleic acid in rat pituitary cells. Endocrinology 134:432-440
51. Maurer RA 1982 Estradiol regulates the transcription of the prolatin gene. J Biol Chem 257:2133-2136
52. Schomburg L, Bauer K 1997 Regulation of the adenohypophysial thyrotropin-releasing hormone-degrading ectoenzyme by estradiol. Endocrinology 138:3587-3593
53. Mitani M, Kaji H, Abe H, Chihara K 1996 Growth hormone (GH)-releasing peptide and GH releasing hormone stimulate GH release from subpopulations of somatotrophs in rats. J Neuroendocrinol 8:825-830
54. Porter TE, Hill JB, Wiles CD, Frawley LS 1990 Is the somatotrope a transitional cell for the functional interconversion of growth hormone- and prolactin-secrering cells? Suggestive evidence for virgin, gestating and lactaring rats. Endocrinology 127:2789-2794
55. Kineman RD, Faught WJ, Frawley LS 1992 Steroids can modulate transdifferentiation of prolactin and growth hormone cells in bovine pituitary cultures. Endocrinology 130:3289-3294
56. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY 1997 The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J Clin Endocrinol Metab 82:590-599
57. Loche S, Colao A, Cappa M, Bellone J, Aimaretti G, Farello G, Faedda A, Lombardi G, Deghenghi R, Ghigo E 1997 The growth hormone response to hexarelin in children: reproducibility and effect of sex steroids. J Clin Endocrinol Metab 82:861-864